Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora July 15, 2025
Lantern Pharma Unveils Groundbreaking AI-Powered Module to Predict Activity and Efficacy of Combination Regimens in Clinical Cancer Treatment July 15, 2025
ESSA Pharma Inc. Announces Definitive Agreement to be Acquired by XenoTherapeutics, Inc., Backed by XOMA Royalty Corporation in All-Cash Transaction July 14, 2025
Immix Biopharma Announces Class-Leading Safety Profile, Allowing Potential Future Indication Expansion July 11, 2025